• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FLOWONIX MEDICAL, INC. PROMETRA II PROGRAMMABLE PUMP; IMPLANTABLE INFUSION PUMP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FLOWONIX MEDICAL, INC. PROMETRA II PROGRAMMABLE PUMP; IMPLANTABLE INFUSION PUMP Back to Search Results
Model Number 13827
Device Problem Use of Device Problem (1670)
Patient Problems Dizziness (2194); Lethargy (2560)
Event Date 06/18/2022
Event Type  Injury  
Event Description
A patient contacted technical solutions to report a pocket fill that occurred at their last refill.They reported that a nurse performed a routine pump refill and shortly after the refill, they became dizzy and lethargic.The nurse reportedly delivered narcan to the patient and drained their pump prior to calling emergency services.Patient stated that there was a pocket fill of 12-13ml as less than 8ml was taken out of the pump.The patient was not admitted to the hospital, but were in the emergency room for observation for several hours.Patient reportedly left feeling fine and back to normal.Follow up attempts to the patient's reported nurse were unsuccessful.
 
Manufacturer Narrative
A review of the device history record, which includes verification of all steps in the manufacturing of the pump, verification of all final testing performed by/on the pump, verification of sterilization, and packaging for subject pump was performed.The review did not identify any non-conformances, issues or capas associated with pump function.Device remains implanted and was not returned for additional evaluation and investigation.The alleged issue was reported by the patient, but not able to be confirmed by the patient's nurse.If additional information becomes available, a supplemental mdr will be sent.Internal complaint number: (b)(4).
 
Event Description
Per follow-up with nurse, they were unable to confirm this event occurred.Nurse reportedly did not see the patient in the month the event was reported and stated they are the only nurse that sees this patient.
 
Manufacturer Narrative
No further information regarding the patient's alleged event could be identified.A supplemental mdr will be sent if additional information becomes available.Internal complaint number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMETRA II PROGRAMMABLE PUMP
Type of Device
IMPLANTABLE INFUSION PUMP
Manufacturer (Section D)
FLOWONIX MEDICAL, INC.
500 international drive
suite 200
mount olive NJ 07828
Manufacturer (Section G)
FLOWONIX MEDICAL, INC.
120 forbes blvd
suite 170
mansfield MA 02048
Manufacturer Contact
james bennett
500 international drive
suite 200
mount olive, NJ 07828
9734269229
MDR Report Key15854044
MDR Text Key304208464
Report Number3010079947-2022-00197
Device Sequence Number1
Product Code LKK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P080012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/23/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/23/2021
Device Model Number13827
Device Catalogue Number13827
Device Lot Number27294
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/03/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/23/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-